Application Detail

Description of Medical Service

Dexcom ONE is a real time continuous glucose monitoring (RT-CGM) system consisting of a wearable sensor and transmitter which transmits data to a compatible smart device via a mobile application. Continuous monitoring allows people with type 2 diabetes (T2D) to accurately monitor their blood glucose levels in real time, helping them make informed decisions to manage their condition and reduce the risk of diabetes-related complications.

Description of Medical Condition

T2D is a condition in which the body becomes resistant to the normal effects of insulin and gradually loses the capacity to produce enough insulin in the pancreas. This leads to high blood sugar (glucose) levels. T2D is the most common form of diabetes and is more likely to occur in those with a family history of the condition, although its development can also be associated with lifestyle factors.

Initially, T2D can often be managed with lifestyle modification such as healthy eating and regular exercise. However, many people with T2D will also need to take medication and many eventually require insulin injections to reduce the complications associated with the condition such as nerve damage, kidney disease and heart disease.

Reason for Application

National Diabetes Service Scheme funding

Medical Service Type

Investigative technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Summary and PICO Set

Application Summary (PDF 264 KB)
Application Summary (Word 44 KB)

Application PICO Set 1 (PDF 654 KB)
Application PICO Set 1 (Word 368 KB)

Application PICO Set 2 (PDF 668 KB)
Application PICO Set 2 (Word 368 KB)

Consultation Survey

Consultation Survey

PASC Consultation
PASC consultation closes Friday 8 November 2024. Any consultation received after this date will automatically be included in the MSAC consultation for this application.

MSAC Consultation
MSAC consultation TBA – please subscribe to the MSAC email bulletin to be notified when this application is scheduled for MSAC consideration. The bulletin will also advise the closing date for consultation input.

For further information please refer to PASC, ESC, MSAC Key Dates

For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

12-13 December 2024

ESC

-

MSAC

-